AsthmaMate
Asthma Intelligence. Simplified.
AsthmaMate is the first behaviour-change platform that reduces asthma symptoms using measurable breathworks — guided by Airo, your personal AI coach, so you can understand your asthma, train your breathing, and take back control of your life.
Be first to know when we launch · No spam, ever
Most people with asthma manage reactively — reaching for an inhaler when it's already too late. AsthmaMate changes that.
Most asthma apps just log symptoms. AsthmaMate goes further — combining intelligent pattern detection with breathworks techniques designed specifically for you.
It's not just a breathing problem. It's a living problem. Sound familiar?
These aren't features. These are the real-life changes our users tell us about.
Spot evening risk patterns before they become 3am emergencies. Wake up rested, not gasping.
Understand which conditions make activity safe — and move with real confidence again.
Most people with asthma have never identified their personal triggers. AsthmaMate's AI analyses your patterns to show you exactly what's affecting you.
Shift from reactive panic to proactive management. Catch warning signs before they escalate.
Show up to appointments with real data. Get more specific advice. Finally feel heard.
No generic exercises. AI recommends techniques based on your specific patterns — and short video guides show you exactly how to do them.
One tap to access a clinically-informed breathing technique designed to help you through an acute attack — calm, clear, and always available.
Complete the breathworks exercise from your bespoke daily plan and the system automatically records it to your log. No manual entry — your breathing activity, symptoms, and environment are all captured in one seamless step.
AsthmaMate cross-references your data with pollen, weather, air quality, and activity — then recommends specific breathworks techniques matched to your unique triggers and breathing profile. The more you use it, the smarter it gets.
Short instructional videos guide you through the techniques recommended for you. Alerts warn you before high-risk periods. And if an attack strikes — your emergency breathworks technique is always one tap away.
Doctor-shareable reports give your GP or specialist a full picture — symptoms, triggers, breathing trends, and your progress over time. Finally have the conversation your asthma deserves.
These are verified UK statistics — not projections, not estimates. This is the reality for millions of people living with asthma today.
"5.4 million people in the UK are currently receiving treatment for asthma — that's 1 in every 12 adults and 1 in every 11 children."
"Around 3 people die from an asthma attack every day in the UK. Experts believe up to 90% of these deaths could be prevented with better care and self-management."
"The NHS spends over £1 billion a year treating asthma. Yet most people living with it have never had a personalised plan — and many don't know their own triggers."
AsthmaMate is pre-launch. We don't have user reviews yet — and we won't fake them.
Join the waitlist now and help shape the product. Early members will be our first beta testers.
Launching soon. Waitlist members get early access, a founder discount, and first look at new features.
We are not building an app. We are building a proprietary clinical data engine. Each phase funds and fuels the next.
We are acquiring a high-retention user base and building the Clean Data Pipeline. Unlike competitors who collect messy, unstructured notes, AsthmaMate uses a Structured Clinical Input method — FHIR-compatible, AI-ready, and built for longitudinal analysis.
Target: High-fidelity dataset · User growth · Behavioural retention
Once sufficient longitudinal data is accumulated, we deploy the Flare-Up Prediction Engine — alerting users before symptoms escalate into attacks. This is the moat: proprietary, real-world asthma behaviour data that no competitor can replicate.
Target: Prediction accuracy · B2B pilot programmes · RPM integration
Formal clinical validation of breathworks outcomes, regulatory pathway exploration, and monetisation of real-world evidence (RWE) — providing anonymised datasets to pharma for clinical trials and to insurers to reduce avoidable ED visits.
Target: NHS partnerships · Pharma RWE licensing · Insurance B2B2C
"We are in the Data Priming phase."
We are acquiring the high-retention user base now to fuel the proprietary predictive models of tomorrow. This is a strategic choice — not a technical limitation.
Every architectural decision we've made is designed to be plug-and-play with hospital systems, insurers, and regulatory bodies from day one.
Our data is structured to the Fast Healthcare Interoperability Resources (FHIR) standard — the same standard used by NHS Digital and US hospital systems. This means our data can be plugged directly into clinical systems without any translation layer.
While other apps collect unstructured symptom notes, AsthmaMate uses validated clinical input frameworks. Every data point is tagged, timestamped, and categorised — producing longitudinal datasets that are genuinely useful for AI modelling and research.
Full GDPR compliance, end-to-end encryption, and user-controlled data sovereignty. Users can export or delete their data at any time. Anonymised aggregate data may be used for research — always with explicit, informed consent.
AsthmaMate is being built to support Remote Patient Monitoring (RPM) — enabling clinicians to monitor high-risk patients between appointments via a clinical dashboard, reducing emergency admissions and improving outcomes.
Founder, AsthmaMate
Asthma sufferer & developer of
The Asthma Breath
"I've had asthma my whole life. And for most of that time, I managed it the same way everyone does — reactively. Inhaler in my pocket. Hope for the best."
Like millions of people, I tried the apps. I logged my symptoms. I noted my triggers. But nothing connected the dots for me. Nothing told me why things were getting worse, or gave me tools to actively improve my breathing — not just record that it was bad.
Out of frustration — and necessity — I developed my own breathing technique. I used it during real attacks. It worked. And I started to wonder: what if I could build something that gave every asthma sufferer access to this, personalised to them, guided by AI?
That's AsthmaMate. Not a passive logger. A behaviour-change platform. Built by someone who lives with asthma, for everyone who does.
Developed through years of personal experience managing acute asthma episodes, The Asthma Breath is a structured breathing technique designed to help regain control during an attack. It's built into AsthmaMate — always one tap away when you need it most.
The biggest challenge in chronic illness management isn't the technology — it's getting people to keep using it. Airo is designed around the psychology of long-term behaviour change.
Airo uses CBT-informed prompts to help users identify and reframe anxiety around asthma — a known driver of symptom escalation. The goal is not just physical improvement but a changed relationship with the condition.
Airo's daily touchpoints are designed using habit loop science — cue, routine, reward — to make breathworks a non-negotiable part of the day, not a chore. This is where Big Tech struggles: the human side of chronic illness.
The more a user engages, the more Airo learns. Plans adapt in real time based on outcomes, adherence, and environmental context — creating a feedback loop that deepens with every session and drives the retention that fuels our data moat.
AsthmaMate is designed with multiple revenue streams — from individual users to enterprise healthcare.
Free tier with core symptom logging and basic breathworks exercises to drive adoption and build the user base.
Live at Launch£9.99/month unlocks full AI insights, personalised breathworks programmes, Airo coaching, and doctor-shareable reports.
Live at LaunchClinics (RPM): A clinical dashboard for GPs to monitor high-risk patients remotely, reducing avoidable admissions.
Life Sciences (RWE): Anonymised real-world evidence datasets licensed to pharma for clinical trials.
Insurers (B2B2C): Partnering with insurers to reduce costly, avoidable ED visits — saving them thousands per patient.
Future integrations with smart inhalers, wearables, and spirometers to enable passive data capture and deeper clinical insights.
Future RoadmapWe're building the first behaviour-change platform for the 5.4 million people in the UK living with asthma. Propeller Health proved the market at $225M — we're filling the gap they left, with no hardware, no prescription, and AI at the core.
Apple and Big Pharma are horizontal — they track everything for everyone. AsthmaMate is vertical. Our moat is hyper-specialised engagement, proprietary clinical data, and a Data Network Effect that grows with every user.
As our user base grows, we are building the world's most granular dataset of asthma behaviours and breathworks outcomes — real-world evidence that Big Pharma and insurers actively want to license for R&D.
The patient is the user. The payer is the customer. NHS, insurers, and employers pay to reduce avoidable ED visits — each of which costs thousands. Our B2B2C model doesn't depend on app store subscriptions.
All enquiries are treated in strict confidence.
Be among the founding members who helped shape AsthmaMate — and be first to access it when we launch.
Reserve My Spot on the WaitlistFree to join · Early-bird pricing for waitlist members · No card needed